The expression of p-ATF2 involved in the chondeocytes apoptosis of an endemic osteoarthritis, Kashin-Beck disease

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Han, Jing ^a   Guo, Xiong ^a   Tan, Wuhong ^a   Zhang, Feng ^a   Liu, Jiangtao ^a   Wang, Weizhuo ^a   Xu, Peng ^b   Lammi, Mikko J ^c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Red Cross Hospital   (China)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Apoptosis; ATF2; Cartilage; Chondrocytes; JNK and p38 pathways; Kashin Beck disease

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; ATF2 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN TISSUE; KASHIN BECK DISEASE; MALE; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; KASHIN-BECK DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ACTIVATING TRANSCRIPTION FACTOR 2; ADULT; APOPTOSIS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KASHIN-BECK DISEASE; MALE; MIDDLE AGED; OSTEOARTHRITIS;

EID: 84880101194     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-209     Document Type: Article

References (38)

1. Report of a national survey of Kashin-Beck disease prevalence in 2005. National Kashin-Beck Disease Surveillance Group, Chin J Endemiol 2006 25 670 672
2. China Ministry of Health statistics and information center, Prevention and control of endemic diseases China Health Statistics Annual Report. 2010 http://www.moh.gov.cn/htmlfiles/zwgkzt/ptjnj/year2011/index2011.html
3. Kashin-Beck disease: a historical overview. Yamamuro T, Int Orthop 2001 25 134 137 10.1007/s002640000178 11482525 (Pubitemid 32606136)
4. Progression and prospect of etiology and pathogenesis of Kashin-Beck disease in China. Guo X, Chin J Endemiol 2008 27 6 8
5. Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Zou K, Liu G, Wu T, et al. Osteoarthr Cartilage 2009 17 144 151 10.1016/j.joca.2008.06.011
6. Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats. Ren FL, Guo X, Zhang RJ, et al. Osteoarthr Cartilage 2007 15 1171 1177 10.1016/j.joca.2007.03. 013 (Pubitemid 47387044)
7. The role of humic substances in drinking water in Kashin-Beck disease in China. Peng A, Wang WH, Wang CX, et al. Environ Health Persp 1999 107 293 296 10.1289/ehp.99107293 (Pubitemid 29231632)
8. A role of low selenium in the occurrence of Kashin-Beck disease. Guo X, Zhang SY, Mo DX, J Xi'an Jiaotong Univ (Med Sci) 1992 4 99 108 23884648
9. Selenium in soil and endemic diseases in China. Tan JA, Zhu WY, Wang WY, et al. Sci Total Environ 2002 284 227 235 10.1016/S0048-9697(01)00889-0 11846167 (Pubitemid 34059282)
10. Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue: an animal model to study the molecular defects of Kashin-Beck disease. Yang CL, Niu CR, Bodo M, et al. Biochem J 1993 289 829 835 8435081 (Pubitemid 23074971)
11. Serum hyaluronic acid, tumor necrosis factor-a, vascular endothelial growth factor, NO, and Se levels in adult patients with Kashin-Beck disease. Li XY, Guo X, Wang LX, et al. J South Med Univ 2007 27 941 944
12. Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck Disease. Wang W, Guo X, Chen JC, et al. J Rheumatol 2008 35 696 702 18322983 (Pubitemid 351500069)
13. Electron microscope of Kashin-Beck patients with articular cartilage and epiphyseal cartilage chondrocytes. Mo DX, J Xi'an Jiaotong Univ (Med Sci) 1979 3 34 39 23884648
14. Genome-wide gene expression analysis suggests immunity in pathogenesis of Kashin-Beck disease. Wang S, Guo X, Wu XM, et al. PLoS One 2012 7 28439 10.1371/journal.pone.0028439 22235245
15. China Ministry of Public Health, Diagnosis of Kaschin-Beck disease http://www.moh.gov.cn/zwgkzt/s9500/201006/47920/files/ 810f8a8b47cf434195a59c071a97bdc0.pdf
16. Differential regulation and properties of MAPKs. Raman M, Chen W, Cobb MH, Oncogene 2007 26 3100 3112 10.1038/sj.onc.1210392 17496909 (Pubitemid 46763006)
17. p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Kumar S, Boehm J, Lee JC, Nat Rev Drug Discov 2003 2 717 726 10.1038/nrd1177 12951578 (Pubitemid 37361787)
18. JNK signaling in apoptosis. Dhanasekaran DN, Reddy EP, Oncogene 2008 27 6245 6251 10.1038/onc.2008.301 18931691
19. Activation and signaling of the p38 MAP kinase pathway. Zarubin T, Han J, Cell Res 2005 15 11 18 10.1038/sj.cr.7290257 15686620 (Pubitemid 41653958)
20. Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Wang WZ, Guo X, Duan CH, et al. Osteoarthr Cartilage 2009 17 83 90 10.1016/j.joca.2008.05.008
21. Abnormal expression of Col X, PTHrP, TGF-β, bFGF, and VEGF in cartilage with Kashin-Beck disease. Guo X, Zuo H, Cao CX, et al. J Bone Min Metab 2006 24 319 328 10.1007/s00774-006-0690-3 (Pubitemid 43992676)
22. Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Guo X, Int Orthop 2001 25 147 150 10.1007/s002640100248 11482528 (Pubitemid 32606139)
23. Analysis of relative gene expression data using Real-Time quantitative PCR and the 2§ssup§-C§esup§§ssup§ T §esup§ method. Kenneth JL, Thomas DS, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
24. Articular cartilage metabolism in patients with Kashin-Beck disease: an endemic osteoarthropathy in China. Cao JL, Li SY, Shi ZL, et al. Osteoarthr Cartilage 2008 16 680 688 10.1016/j.joca.2007.09.002 (Pubitemid 351753709)
25. Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease. Wang SJ, Guo X, Zuo H, et al. J Rheumatol 2006 33 615 619 16511931 (Pubitemid 43334588)
26. The changes of nitric oxide, NO syntheses and Fas/APO-1 in serum among the patients with Kashin-Beck disease. Zhang BD, Guo X, Bai GL, et al. Chin J Entomol 2006 23 172 175
27. Culture rabbit chondrocytes with serum from children with Kashin- Beck disease. Wei XQ, Zhang J, Cao JL, et al. Chin J Endemiol 1990 9 90 93
28. Effect of serum of KBD patients on metabolism of proteoglycan in rabbit hypertrophic chondrocyte cultures. Yan WQ, Yu L, Cunmaofu Z, et al. Chin J Endemiol 1994 13 323 325
29. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Gupta S, Campbell D, Dérijard B, et al. Science 1995 267 389 393 10.1126/science.7824938 7824938
30. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Ip YT, Davis RJ, Curr Opin Cell Biol 1998 10 205 219 10.1016/S0955-0674(98)80143-9 9561845 (Pubitemid 28174763)
31. Reative oxygen species mediate crosstalk between NF- κB and JNK. Nakano H, Nakajima A, Sakon SK, et al. Cell Death Differ 2006 13 730 737 10.1038/sj.cdd.4401830 16341124
32. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway. Hwang SG, Yu SS, Lee SW, et al. FEBS Lett 2005 579 4837 4842 10.1016/j.febslet.2005.07.067 16099458 (Pubitemid 41218672)
33. Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Arbogast S, Ferreiro A, Antioxid Redox Sign 2010 12 893 904 10.1089/ars.2009. 2890
34. Regulation and function of selenoproteins in human disease. Bellinger FP, Raman AV, Reeves MA, et al. Biochem J 2009 422 11 22 10.1042/BJ20090219 19627257
35. Effect of T-2 mycotoxin on rat liver mitochondria electron transport system. Pace JG, Toxicon 1983 21 675 680 10.1016/0041-0101(83)90273-8 6648984 (Pubitemid 14237681)
36. Mitochondrial function is altered in articular chondrocytes of an endemic osteoarthritis, Kashin-Beck disease. Liu JT, Guo X, Ma WJ, et al. Osteoarthr Cartilage 2010 18 1218 1226 10.1016/j.joca.2010.07.003
37. Histopathology of chondronecrosis development in knee articular cartilage in a rat model of Kashin-Beck disease using T-2 toxin and selenium deficiency conditions. Guan F, Li SY, Wang ZL, et al. Rheumatol Int 2013 33 157 166 10.1007/s00296-011-2335-7 22258458
38. Synthesis and characterization of selenium-chondroitin sulfate nanoparticles. Han J, Guo X, Lei YX, et al. Carbohyd Polym 2012 90 122 126 10.1016/j.carbpol.2012.04.068